HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 1,093: | Line 1,093: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|IgG4-related disease | |IgG4-related disease | ||
| Line 1,109: | Line 1,109: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Unicentric Castleman disease | |Unicentric Castleman disease | ||
| Line 1,125: | Line 1,125: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|Idiopathic multicentric Castleman disease | |Idiopathic multicentric Castleman disease | ||
| Line 1,141: | Line 1,141: | ||
| | | | ||
| | | | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
| | |NEW (No Prior) | ||
|- | |- | ||
|KSHV/HHV8-associated multicentric Castleman disease | |KSHV/HHV8-associated multicentric Castleman disease | ||
| Line 1,157: | Line 1,157: | ||
| | | | ||
| | | | ||
| | |Multicentric Castleman Disease | ||
|Sudha Arumugam, MD | |Sudha Arumugam, MD | ||
| | |Complete | ||
| | |01/24/2022 | ||
| | |Date completed by author: 01/24/2022 | ||
|- | |- | ||
|B-lymphoblastic leukaemia/lymphoma | |B-lymphoblastic leukaemia/lymphoma | ||